Search

Your search keyword '"Bonow, Robert O"' showing total 12 results
Start Over Author "Bonow, Robert O" Journal american heart journal
12 results on '"Bonow, Robert O"'

1. Improving cardiovascular clinical trials conduct in the United States: Recommendation from clinicians, researchers, sponsors, and regulators

Author

Butler, Javed, Fonarow, Gregg C., O’Connor, Christopher, Adams, Kirkwood, Bonow, Robert O., Cody, Robert J., Collins, Sean P., Dunnmon, Preston, Dinh, Wilfried, Fiuzat, Mona, Georgiopoulou, Vasiliki V., Grant, Stephen, Kim, So-Young, Kupfer, Stuart, Lefkowitz, Martin, Mentz, Robert J., Misselwitz, Frank, Pitt, Bertram, Roessig, Lothar, Schelbert, Erik, Shah, Monica, Solomon, Scott, Stockbridge, Norman, Yancy, Clyde, and Gheorghiade, Mihai

Published
2015
Full Text
View/download PDF

4. Troponin I elevation and cardiac events after percutaneous coronary intervention

Author

Ricciardi, Mark J., Davidson, Charles J., Gubernikoff, George, Beohar, Nirat, Eckman, Lorene J., Parker, Michele A., and Bonow, Robert O.

Subjects
Cardiac patients -- Medical examination, Cardiac patients -- Surveys, Cardiac patients -- Care and treatment, Coronary heart disease -- Diagnosis, Coronary heart disease -- Care and treatment, Health
Published
2003

5. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

Author

Henry, Timothy D., Rocha-Singh, Krishna, Isner, Jeffrey M., Kereiakes, Dean J., Giordano, Frank J., Simons, Michael, Losordo, Douglas W., Hendel, Robert C., Bonow, Robert O., Eppler, Stephen M., Zioncheck, Thomas F., Holmgren, Eric B., and McCluskey, Edward R.

Subjects
Coronary heart disease -- Care and treatment, Vascular endothelial growth factor -- Health aspects, Health
Published
2001

8. The pathophysiology of advanced heart failure

Author

Baig, M. Kamran, Mahon, Niall, McKenna, William J., Caforio, Alida L.P., Bonow, Robert O., Francis, Gary S., and Gheorghiade, Mihai

Subjects
Heart failure -- Physiological aspects, Health
Published
1998

12. beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.

Author

Goldberger JJ, Bonow RO, Cuffe M, Dyer A, Rosenberg Y, O'Rourke R, Shah PK, Smith SC Jr, PACE-MI Investigators, Goldberger, Jeffrey J, Bonow, Robert O, Cuffe, Michael, Dyer, Alan, Rosenberg, Yves, O'Rourke, Robert, Shah, Prediman K, and Smith, Sidney C Jr

Abstract

Background: Quality improvement programs have shown increased use of beta-blockers post-myocardial infarction (MI), but there are no data on whether appropriate doses are administered.Methods: In a prospective registry that enrolled consecutive patients with MI, we evaluated beta-blocker dosing at discharge after MI and 3 weeks later and assessed clinical predictors for treatment with very low doses. We studied 1,971 patients (70.8% male) with a mean age of 63.9 +/- 13.7 years, of whom 48.2% had an ST-elevation MI.Results: beta-Blocker utilization rates following MI were 93.2% at discharge: 20.1% received <25% of target dose, 36.5% received 25% of target dose, 26.4% received 26% to 50% of target dose, and 17.0% received >50% of target dose. Between discharge and 3 weeks, 76.4% had no change in beta-blocker dose, with 11.9% and 11.6% having their dose reduced and increased, respectively. Absence of hypertension, acute percutaneous coronary intervention, older age, and no angiotensin-converting enzyme inhibitor therapy were consistent predictors of treatment with very low beta-blocker doses.Conclusions: Underdosing of beta-blockers is highly prevalent among patients post-MI. This represents an important opportunity in quality improvement for the care of patients who have suffered an MI. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results